A highly skilled, passionate scientist with proven FDA approved product track record experienced in the development of novel drug delivery technologies and translational clinical products.
Pre-formulation, R&D screening, GMP manufacturing (oral solid pilot and exhibit batches), documentation (batch records, protocols, summary reports), regulatory preparation of CMC sections module-3 (32P), reviewing of Module-3 (32S), clinical review of clinical protocols, animal studies, familiar with WinNonlin software, operations blender, tablet press, tablet/pellet coaters, granulators, hot melt extruder, IOQ/PQ, quality assurance GMP facility maintenance, environmental monitoring, project management timeline, tracking daily schedule, drafting budgets, new project assessments/setting up TPP, logistics excipient inventory management and procurement expertise in topical rings/gels, injectables (generic R&D), polymeric micro-nano particles-targeted delivery of small molecule/peptide, lipid nanoparticles (microfluidics)-peptide loaded, and various FRD&ARD analytical tools
Orthopaedic Research Society (ORS); American Association of Pharmaceutical Sciences (AAPS); Controlled Release Society (CRS); Society for Polymer Science (SPS); Reviewer of over 10 international scientific journals including Pharmaceutical Research, and Nanomedicine: Nanotechnology, Biology, and Medicine.
FDA Approved Product: (1) PB ER 105 mg tablet formulation (505 (b)(2)) for once-daily oral administration approved October 2024 https://lnkd.in/ePXN7paP; (2) Oral solid IR tablets manufactured using hot melt extrusion.
US Patents (Granted): Extended-release compositions comprising pyridostigmine (for pellet/gastro-retentive tablets), US 10,925,833 B2, 2020; Extended release multi-particulate capsule formulation comprising trihexyphenidyl hydrochloride, US11684580B2, 2023; Gastro-retentive dosage forms for sustained drug delivery, US11318091B2, 2022; Intravaginal reservoir ring devices for drug delivery (WO Patent 2,013,013, 172).
Peer reviewed research articles: Role of plasticizer in membrane coated extended-release oral drug delivery system, Journal of Drug Delivery Science and Technology, 2018, 44, 231-243; Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy, PLoS ONE. 2014, 9(3), e88509; Intravitreal poly(L-lactide) microparticles for sustained retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases, Drug Delivery and Translational Research 2010, 1 (1), 76.
Book Chapters: "Polyurethanes" in “Natural and synthetic biomedical polymers” Elsevier Science, 2014, 123-144; “Polyester nano-and micro-technologies for tissue engineering” in “Handbook of Polyester Drug Delivery Systems” Pan Stanford Publishing 2016, Chapter 18, 595-650.